ICD-10 category · Morphology of neoplasms · M995-M997
M996 Chronic myeloprpliferative disorders
19 codes under M996 in the South African Master Industry Table 2021, 16 valid for clinical use.
| Code | Description | Use | Benefits |
|---|---|---|---|
| M9960/1 | Chronic myeloproliferative disease (D47.1)Discontinued in South Africa from 31 May 2013 | Discontinued | — |
| M9960/3 | Myeloproliferative neoplasm, NOS, malignant, primary site | Valid · not as primary | — |
| M9960/6 | Myeloproliferative neoplasm, NOS, malignant, metastatic site | Valid · not as primary | — |
| M9961/1 | Myelosclerosis with myeloid metaplasia (D47.1)Discontinued in South Africa from 31 May 2013 | Discontinued | — |
| M9961/3 | Primary myelofibrosis, malignant, primary site | Valid · not as primary | — |
| M9961/6 | Primary myelofibrosis, malignant, metastatic site | Valid · not as primary | — |
| M9962/1 | Idiopathic thrombocythaemia (D47.3)Discontinued in South Africa from 31 May 2013 | Discontinued | — |
| M9962/3 | Essential thrombocythemia, malignant, primary site | Valid · not as primary | — |
| M9962/6 | Essential thrombocythemia, malignant, metastatic site | Valid · not as primary | — |
| M9963/3 | Chronic neutrophilic leukaemia, malignant, primary site | Valid · not as primary | — |
| M9963/6 | Chronic neutrophilic leukaemia, malignant, metastatic site | Valid · not as primary | — |
| M9964/3 | Chronic eosinophillic leukaemia, NOS, malignant, primary site | Valid · not as primary | — |
| M9964/6 | Chronic eosinophillic leukaemia, NOS, malignant, metastatic site | Valid · not as primary | — |
| M9965/3 | Myeloid and lymphoid neoplasms with PDGFRA rearrangement, malignant, primary site | Valid · not as primary | — |
| M9965/6 | Myeloid and lymphoid neoplasms with PDGFRA rearrangement, malignant, metastatic site | Valid · not as primary | — |
| M9966/3 | Myeloid and lymphoid neoplasms with PDGFRB rearrangement, malignant, primary site | Valid · not as primary | — |
| M9966/6 | Myeloid and lymphoid neoplasms with PDGFRB rearrangement, malignant, metastatic site | Valid · not as primary | — |
| M9967/3 | Myeloid and lymphoid neoplasms with FGFR1 abnormalities, malignant, primary site | Valid · not as primary | — |
| M9967/6 | Myeloid and lymphoid neoplasms with FGFR1 abnormalities, malignant, metastatic site | Valid · not as primary | — |
Source and terms
Reproduced from the national table, unaltered.
The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page
Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.
ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.
Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.
Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.
In GreenNotes
Code the consultation once. The invoice and the claim pick it up.
GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.